APO RESEARCH · REPORT
Radiofrequency Ablation for Pain Management
A radiofrequency ablation is a minimally invasive procedure that destroys the nerve fibers carrying pain signals to the brain. It can provide lasting relief for people with chronic pain, especially in the lower back, neck and arthritic joints.
Product & engineering
Understand the product.
A radiofrequency ablation is a minimally invasive procedure that destroys the nerve fibers carrying pain signals to the brain. It can provide lasting relief for people with chronic pain, especially in the lower back, neck and arthritic joints.
Radiofrequency ablation, also called rhizotomy, is a nonsurgical, minimally invasive procedure that uses heat to reduce or stop the transmission of pain. Radiofrequency waves ablate, or "burn," the nerve that is causing the pain, essentially eliminating the transmission of pain signals to the brain.
This procedure is most commonly used to treat chronic pain and conditions such as arthritis of the spine (spondylosis) and sacroilitis. It is also used to treat neck, back, knee, pelvic and peripheral nerve pain. The benefits of radiofrequency ablation include avoiding surgery, immediate pain relief, little to no recovery time, decreased need for pain medication, improved function, and a quicker return to work and other activities.
Selected research
Market Analysis & Forecast
Global Radiofrequency Ablation for Pain Management Market Analysis and Forecast 2026-2032
Market perspective
A radiofrequency ablation is a minimally invasive procedure that destroys the nerve fibers carrying pain signals to the brain. It can provide lasting relief for people with chronic pain, especially in the lower back, neck and arthritic joints.
Radiofrequency ablation, also called rhizotomy, is a nonsurgical, minimally invasive procedure that uses heat to reduce or stop the transmission of pain. Radiofrequency waves ablate, or "burn," the nerve that is causing the pain, essentially eliminating the transmission of pain signals to the brain.
This procedure is most commonly used to treat chronic pain and conditions such as arthritis of the spine (spondylosis) and sacroilitis. It is also used to treat neck, back, knee, pelvic and peripheral nerve pain. The benefits of radiofrequency ablation include avoiding surgery, immediate pain relief, little to no recovery time, decreased need for pain medication, improved function, and a quicker return to work and other activities.
Read the full market overview
A radiofrequency ablation is a minimally invasive procedure that destroys the nerve fibers carrying pain signals to the brain. It can provide lasting relief for people with chronic pain, especially in the lower back, neck and arthritic joints.Based on product type, the radiofrequency ablation for pain management market has been segmented into RF generators, reusable (probes, electrodes), and disposable (cannula, needles, single-use probes, and single-use electrodes). Of these, the segment of disposable products, accounted for over 43.9% of the global market in 2019.Radiofrequency Ablation for Pain Management is widely sold in Hospital, Clinic. The most proportion of Radiofrequency Ablation for Pain Management is sold in Hospital, and the proportion in 2019 is 66.9%.
North America is the largest Sales place, with a Sales market share nearly 48.3% in 2019. Following North America, Europe is the second largest Sales place with the Sales market share of 24.2%.
Market competition is intense. Abbott (St. Jude Medical), Avanos Medical, Stryker, Boston Scientific, etc.
Report Includes
This report presents an overview of global market for Radiofrequency Ablation for Pain Management, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Radiofrequency Ablation for Pain Management, also provides the revenue of main regions and countries. Of the upcoming market potential for Radiofrequency Ablation for Pain Management, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Radiofrequency Ablation for Pain Management revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Radiofrequency Ablation for Pain Management market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Radiofrequency Ablation for Pain Management revenue, projected growth trends, production technology, application and end-user industry.
Radiofrequency Ablation for Pain Management Segment by Company
Abbott (St. Jude Medical)
Avanos Medical
Stryker
Boston Scientific
Medtronic
Diros Technology
Radiofrequency Ablation for Pain Management Segment by Type
RF Generators
Reusable Products
Disposable Products
Radiofrequency Ablation for Pain Management Segment by Application
Hospital
Clinic
Other
Radiofrequency Ablation for Pain Management Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radiofrequency Ablation for Pain Management market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Radiofrequency Ablation for Pain Management and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radiofrequency Ablation for Pain Management.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Radiofrequency Ablation for Pain Management in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Radiofrequency Ablation for Pain Management company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Radiofrequency Ablation for Pain Management revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- RF Generators
- Reusable Products
- Disposable Products
Applications
- Hospital
- Clinic
- Other
Companies covered
- Abbott (St. Jude Medical)
- Avanos Medical
- Stryker
- Boston Scientific
- Medtronic
- Diros Technology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Radiofrequency Ablation for Pain Management Market by Type
- 1.2.1 Global Radiofrequency Ablation for Pain Management Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 RF Generators
- 1.2.3 Reusable Products
- 1.2.4 Disposable Products
- 1.3 Radiofrequency Ablation for Pain Management Market by Application
- 1.3.1 Global Radiofrequency Ablation for Pain Management Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Clinic
- 1.3.4 Other
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Radiofrequency Ablation for Pain Management Market Dynamics
- 2.1 Radiofrequency Ablation for Pain Management Industry Trends
- 2.2 Radiofrequency Ablation for Pain Management Industry Drivers
- 2.3 Radiofrequency Ablation for Pain Management Industry Opportunities and Challenges
- 2.4 Radiofrequency Ablation for Pain Management Industry Restraints
3 Global Growth Perspective
- 3.1 Global Radiofrequency Ablation for Pain Management Market Perspective (2021-2032)
- 3.2 Global Radiofrequency Ablation for Pain Management Growth Trends by Region
- 3.2.1 Global Radiofrequency Ablation for Pain Management Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Radiofrequency Ablation for Pain Management Market Size by Region (2021-2026)
- 3.2.3 Global Radiofrequency Ablation for Pain Management Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Radiofrequency Ablation for Pain Management Revenue by Players
- 4.1.1 Global Radiofrequency Ablation for Pain Management Revenue by Players (2021-2026)
- 4.1.2 Global Radiofrequency Ablation for Pain Management Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Radiofrequency Ablation for Pain Management Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Radiofrequency Ablation for Pain Management Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Radiofrequency Ablation for Pain Management Key Players Headquarters & Area Served
- 4.4 Global Radiofrequency Ablation for Pain Management Players, Product Type & Application
- 4.5 Global Radiofrequency Ablation for Pain Management Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Radiofrequency Ablation for Pain Management Market CR5 and HHI
- 4.6.3 2025 Radiofrequency Ablation for Pain Management Tier 1, Tier 2, and Tier 3
5 Radiofrequency Ablation for Pain Management Market Size by Type
- 5.1 Global Radiofrequency Ablation for Pain Management Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Radiofrequency Ablation for Pain Management Revenue by Type (2021-2032)
- 5.3 Global Radiofrequency Ablation for Pain Management Revenue Market Share by Type (2021-2032)
6 Radiofrequency Ablation for Pain Management Market Size by Application
- 6.1 Global Radiofrequency Ablation for Pain Management Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Radiofrequency Ablation for Pain Management Revenue by Application (2021-2032)
- 6.3 Global Radiofrequency Ablation for Pain Management Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Abbott (St. Jude Medical)
- 7.1.1 Abbott (St. Jude Medical) Company Information
- 7.1.2 Abbott (St. Jude Medical) Business Overview
- 7.1.3 Abbott (St. Jude Medical) Radiofrequency Ablation for Pain Management Revenue and Gross Margin (2021-2026)
- 7.1.4 Abbott (St. Jude Medical) Radiofrequency Ablation for Pain Management Product Portfolio
- 7.1.5 Abbott (St. Jude Medical) Recent Developments
- 7.2 Avanos Medical
- 7.2.1 Avanos Medical Company Information
- 7.2.2 Avanos Medical Business Overview
- 7.2.3 Avanos Medical Radiofrequency Ablation for Pain Management Revenue and Gross Margin (2021-2026)
- 7.2.4 Avanos Medical Radiofrequency Ablation for Pain Management Product Portfolio
- 7.2.5 Avanos Medical Recent Developments
- 7.3 Stryker
- 7.3.1 Stryker Company Information
- 7.3.2 Stryker Business Overview
- 7.3.3 Stryker Radiofrequency Ablation for Pain Management Revenue and Gross Margin (2021-2026)
- 7.3.4 Stryker Radiofrequency Ablation for Pain Management Product Portfolio
- 7.3.5 Stryker Recent Developments
- 7.4 Boston Scientific
- 7.4.1 Boston Scientific Company Information
- 7.4.2 Boston Scientific Business Overview
- 7.4.3 Boston Scientific Radiofrequency Ablation for Pain Management Revenue and Gross Margin (2021-2026)
- 7.4.4 Boston Scientific Radiofrequency Ablation for Pain Management Product Portfolio
- 7.4.5 Boston Scientific Recent Developments
- 7.5 Medtronic
- 7.5.1 Medtronic Company Information
- 7.5.2 Medtronic Business Overview
- 7.5.3 Medtronic Radiofrequency Ablation for Pain Management Revenue and Gross Margin (2021-2026)
- 7.5.4 Medtronic Radiofrequency Ablation for Pain Management Product Portfolio
- 7.5.5 Medtronic Recent Developments
- 7.6 Diros Technology
- 7.6.1 Diros Technology Company Information
- 7.6.2 Diros Technology Business Overview
- 7.6.3 Diros Technology Radiofrequency Ablation for Pain Management Revenue and Gross Margin (2021-2026)
- 7.6.4 Diros Technology Radiofrequency Ablation for Pain Management Product Portfolio
- 7.6.5 Diros Technology Recent Developments
8 North America
- 8.1 North America Radiofrequency Ablation for Pain Management Revenue (2021-2032)
- 8.2 North America Radiofrequency Ablation for Pain Management Revenue by Type (2021-2032)
- 8.2.1 North America Radiofrequency Ablation for Pain Management Revenue by Type (2021-2026)
- 8.2.2 North America Radiofrequency Ablation for Pain Management Revenue by Type (2027-2032)
- 8.3 North America Radiofrequency Ablation for Pain Management Revenue Share by Type (2021-2032)
- 8.4 North America Radiofrequency Ablation for Pain Management Revenue by Application (2021-2032)
- 8.4.1 North America Radiofrequency Ablation for Pain Management Revenue by Application (2021-2026)
- 8.4.2 North America Radiofrequency Ablation for Pain Management Revenue by Application (2027-2032)
- 8.5 North America Radiofrequency Ablation for Pain Management Revenue Share by Application (2021-2032)
- 8.6 North America Radiofrequency Ablation for Pain Management Revenue by Country
- 8.6.1 North America Radiofrequency Ablation for Pain Management Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Radiofrequency Ablation for Pain Management Revenue by Country (2021-2026)
- 8.6.3 North America Radiofrequency Ablation for Pain Management Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Radiofrequency Ablation for Pain Management Revenue (2021-2032)
- 9.2 Europe Radiofrequency Ablation for Pain Management Revenue by Type (2021-2032)
- 9.2.1 Europe Radiofrequency Ablation for Pain Management Revenue by Type (2021-2026)
- 9.2.2 Europe Radiofrequency Ablation for Pain Management Revenue by Type (2027-2032)
- 9.3 Europe Radiofrequency Ablation for Pain Management Revenue Share by Type (2021-2032)
- 9.4 Europe Radiofrequency Ablation for Pain Management Revenue by Application (2021-2032)
- 9.4.1 Europe Radiofrequency Ablation for Pain Management Revenue by Application (2021-2026)
- 9.4.2 Europe Radiofrequency Ablation for Pain Management Revenue by Application (2027-2032)
- 9.5 Europe Radiofrequency Ablation for Pain Management Revenue Share by Application (2021-2032)
- 9.6 Europe Radiofrequency Ablation for Pain Management Revenue by Country
- 9.6.1 Europe Radiofrequency Ablation for Pain Management Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Radiofrequency Ablation for Pain Management Revenue by Country (2021-2026)
- 9.6.3 Europe Radiofrequency Ablation for Pain Management Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Radiofrequency Ablation for Pain Management Revenue (2021-2032)
- 10.2 China Radiofrequency Ablation for Pain Management Revenue by Type (2021-2032)
- 10.2.1 China Radiofrequency Ablation for Pain Management Revenue by Type (2021-2026)
- 10.2.2 China Radiofrequency Ablation for Pain Management Revenue by Type (2027-2032)
- 10.3 China Radiofrequency Ablation for Pain Management Revenue Share by Type (2021-2032)
- 10.4 China Radiofrequency Ablation for Pain Management Revenue by Application (2021-2032)
- 10.4.1 China Radiofrequency Ablation for Pain Management Revenue by Application (2021-2026)
- 10.4.2 China Radiofrequency Ablation for Pain Management Revenue by Application (2027-2032)
- 10.5 China Radiofrequency Ablation for Pain Management Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Radiofrequency Ablation for Pain Management Revenue (2021-2032)
- 11.2 Asia Radiofrequency Ablation for Pain Management Revenue by Type (2021-2032)
- 11.2.1 Asia Radiofrequency Ablation for Pain Management Revenue by Type (2021-2026)
- 11.2.2 Asia Radiofrequency Ablation for Pain Management Revenue by Type (2027-2032)
- 11.3 Asia Radiofrequency Ablation for Pain Management Revenue Share by Type (2021-2032)
- 11.4 Asia Radiofrequency Ablation for Pain Management Revenue by Application (2021-2032)
- 11.4.1 Asia Radiofrequency Ablation for Pain Management Revenue by Application (2021-2026)
- 11.4.2 Asia Radiofrequency Ablation for Pain Management Revenue by Application (2027-2032)
- 11.5 Asia Radiofrequency Ablation for Pain Management Revenue Share by Application (2021-2032)
- 11.6 Asia Radiofrequency Ablation for Pain Management Revenue by Country
- 11.6.1 Asia Radiofrequency Ablation for Pain Management Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Radiofrequency Ablation for Pain Management Revenue by Country (2021-2026)
- 11.6.3 Asia Radiofrequency Ablation for Pain Management Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Radiofrequency Ablation for Pain Management Revenue (2021-2032)
- 12.2 SAMEA Radiofrequency Ablation for Pain Management Revenue by Type (2021-2032)
- 12.2.1 SAMEA Radiofrequency Ablation for Pain Management Revenue by Type (2021-2026)
- 12.2.2 SAMEA Radiofrequency Ablation for Pain Management Revenue by Type (2027-2032)
- 12.3 SAMEA Radiofrequency Ablation for Pain Management Revenue Share by Type (2021-2032)
- 12.4 SAMEA Radiofrequency Ablation for Pain Management Revenue by Application (2021-2032)
- 12.4.1 SAMEA Radiofrequency Ablation for Pain Management Revenue by Application (2021-2026)
- 12.4.2 SAMEA Radiofrequency Ablation for Pain Management Revenue by Application (2027-2032)
- 12.5 SAMEA Radiofrequency Ablation for Pain Management Revenue Share by Application (2021-2032)
- 12.6 SAMEA Radiofrequency Ablation for Pain Management Revenue by Country
- 12.6.1 SAMEA Radiofrequency Ablation for Pain Management Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Radiofrequency Ablation for Pain Management Revenue by Country (2021-2026)
- 12.6.3 SAMEA Radiofrequency Ablation for Pain Management Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst